Baird downgrades Contineum Therapeutics to Neutral on weak ALOFT-IPF high-dose occupancy thesis

Baird downgraded Contineum Therapeutics to Neutral, saying the ALOFT-IPF high-dose data weakens the occupancy thesis.

Detected & updated continuously · Source: Nebula